GnRH analogue in everyday gynecology: Is it possible to rationalize its use?

Acta Obstetricia et Gynecologica Scandinavica

Volumn 78, Issue 4, 1999, Pages 340-345

  Lyall, Helen ^a,c   Campbell Brown, Mary ^a   Walker, James J ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c QUEEN MOTHER S HOSPITAL   (United Kingdom)

Author keywords

Gonadotrophin releasing hormone analog (GnRHa); Menstrual disorder; Pelvic pain

Indexed keywords

GONADORELIN; GOSERELIN; HORMONE ANALOG; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MENSTRUATION DISORDER; OUTCOMES RESEARCH; PELVIS PAIN SYNDROME; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

EID: 0033023439     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1080/j.1600-0412.1999.780413.x     Document Type: Article

References (12)

1. 1. Perry CM, Brogden RN. Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynecological disorders. Drugs 1996; 51: 319-46.
2. 2. Shaw RW and The GnRHa Endometriosis Study Team. An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Fertil Steril 1992; 58: 265-72.
3. 3. Lumsden MA, West CP, Thomas E, Coutts J, Hillier H, Thomas N et al. Treatment with the gonadotrophin releasing hormone agonist goserelin before hysterectomy for uterine fibroids. Br J Obstet Gynaecol 1994; 101: 438-42.
4. ® (goserelin) in the treatment of benign gynecological disorders: an overview of safety and efficacy. Br J Obstet Gynaecol 1992; 99: 37-41.
5. 5. West CP, Hillier H. Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (GnRHa) in management of the premenstrual tension syndrome. Hum Reprod 1994; 9: 1058-83.
6. 6. Fraser IS, Healy DL, Torode H, Song JY, Mamers P, Wilde F. Depot goserelin and danazol pre-treatment before rollerball endometrial ablation for menorrhagia. Obstet Gynecol 1996; 87: 544-50.
7. 7. Rubinow DR. The premenstrual syndrome: new views. JAMA 1992; 268: 1908-12.
8. 8. Coulter A, Bradlow J, Agass M, Martin-Bates C, Tulloch A. Outcomes of referrals to gynecology outpatient clinics for menstrual problems: an audit of general practice records. Br J Obstet Gynaecol 1991; 98: 789-96.
9. 9. Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotrophin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril 1993; 60: 75-9.
10. 10. Carey MP, Slack MC. GnRH analogue in assessing chronic pelvic pain in women with residual ovaries. Br J Obstet Gynaecol 1996; 103: 150-3.
11. 11. Vercellini P, Crosignani PG. Goserelin (GnRHa) and the anaemic patient. Br J Obstet Gynaecol 1994; 101: 33-7.
12. 12. Colacurci N, De Placido G, Mollo A, Perino A, Cittadini E. Short-term use of Goserelin depot in the treatment of dysfunctional uterine bleeding. Clin Exp Obstet Gynecol 1995; 22: 212-19.